CC
SGNT

Carlson Capital’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Carlson Capital’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,351,056
Closed -$20.2M – 344
2016
Q2 		$20.2M Buy
1,351,056
+158,288
+13% +$2.03M 0.25% 128
2016
Q1 		$14.5M Buy
+1,192,768
New +$16.7M 0.17% 164

Carlson Capital's SGNT Position: Q3 2016 in Review

Carlson Capital sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 1,351,056 shares — an estimated $20.2M sold.

Carlson Capital first reported a position in SGNT in Q1 2016 and held it in 2 quarters. The position peaked at $20.2M in Q2 2016. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Carlson Capital reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Carlson Capital sold 1,351,056 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $20.2M.
  • Carlson Capital first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2016 and held it in 2 quarters.
  • Carlson Capital's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $20.2M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Carlson Capital's 13F filing for Q3 2016, filed 14 Nov 2016.